Close Menu

NEW YORK (GenomeWeb) – Roche today said that its Cobas HIV-1 and HCV next-generation viral load monitoring assays have received CE marking.

The Cobas HIV-1 assay simultaneously amplifies and detects two separate regions of the HIV-1 genome to quantify the amount of viral RNA in the patient's blood. The Cobas HCV assay employs the firm's dual-probe approach to detect hepatitis C RNA. Both assays are available for use on the Cobas 6800 and 8800 systems.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Researchers have developed a robotic lab assistant, the Verge reports.

CBC News reports Canada's Supreme Court is to rule on the constitutionality of the country's genetic non-discrimination law today.

The Associated Press reports the World Health Organization is sending experts to China to investigate the animal source of SARS-CoV-2.

In Science this week: atlas of affected cell populations in idiopathic pulmonary fibrosis, and more.